Bodycote (OTCMKTS:BYPLF - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 9,591 shares, a growth of 1,117.1% from the March 15th total of 788 shares. Based on an average daily volume of 204 shares, the days-to-cover ratio is currently 47.0 days. Currently, 0.0% of the shares of the company are short sold.
Bodycote Price Performance
BYPLF remained flat at $10.05 during trading on Friday. Bodycote has a 12 month low of $8.50 and a 12 month high of $10.05. The business's fifty day moving average is $10.05 and its two-hundred day moving average is $9.13.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Jefferies Financial Group restated a "buy" rating on shares of Bodycote in a report on Friday. Royal Bank Of Canada cut shares of Bodycote from a "moderate buy" rating to a "hold" rating in a report on Thursday, March 12th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Bodycote presently has an average rating of "Moderate Buy".
Get Our Latest Stock Report on Bodycote
Bodycote Company Profile
(
Get Free Report)
Bodycote plc OTCMKTS: BYPLF is a global provider of industrial thermal processing and materials technology services. The company offers a range of solutions including heat treatment, hot isostatic pressing, surface coatings and metal joining, all designed to enhance mechanical performance, improve material properties and extend the service life of critical components.
Operating more than 140 facilities across Europe, North America and the Asia-Pacific region, Bodycote serves customers in aerospace, automotive, energy, medical and general industrial markets.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.